HCV, HBV coinfection raises hepatocellular carcinoma risk

09/30/2011 | Medscape (free registration)

Patients with both hepatitis B and C are at higher risk of hepatocellular carcinoma than those with just one of the viruses but age and gender also are factors, Harvard University researchers reported in the Journal of Clinical Oncology. They said antiviral and interferon treatments may reduce the risk of HCC.

View Full Article in:

Medscape (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Actuary
Meridian Health Plan
Detroit, MI
Vice President of Finance
Urban Health Plan, Inc.
Bronx, NY
Director of Payor/Provider Contracting
U.S. Medical Management
Tryo, MI